Waystar Holding Corp. cash flow statement
In fiscal 2025, Waystar Holding Corp.'s operations generated $310m of cash; it spent $26.5m on capital projects, leaving free cash flow of $283m.
Cash flow statement
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|
| Cash from operations | 103 | 51 | 170 | 310 | 315 |
| Depreciation and amortisation | 183 | 176 | 187 | 141 | 165 |
| Stock-based pay | 8 | 9 | 54 | 42 | 62 |
| Capital spending | 17 | 22 | 27 | 26 | 51 |
| Free cash flow | 85 | 30 | 143 | 283 | 264 |
| Free cash flow after stock pay | 77 | 21 | 88 | 241 | 202 |
| Share buybacks | 2 | 1 | 1 | 0 | — |
| Shares issued | 1 | 0 | 2 | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 65 | 64 | 97 | 82 | 67 | 85 | 59 | 104 |
| Depreciation and amortisation | 38 | 33 | 33 | 33 | 40 | 41 | 41 | 41 |
| Stock-based pay | 7 | 7 | 12 | 12 | 12 | 11 | 14 | 24 |
| Capital spending | 6 | 5 | 6 | 6 | 9 | 15 | 16 | 10 |
| Free cash flow | 59 | 59 | 91 | 76 | 57 | 70 | 43 | 94 |
| Free cash flow after stock pay | 52 | 52 | 79 | 65 | 45 | 58 | 29 | 70 |
| Shares issued | 0 | 11 | — | — | — | — | — | — |
Compare with peers
- Omnicell, Inc. cash flow
- Tempus AI, Inc. cash flow
- Goodrx Holdings, Inc. cash flow
- Doximity, Inc. cash flow
- Teladoc Health, Inc. cash flow
Head to head: OMCL vs WAYTEM vs WAYGDRX vs WAYTDOC vs WAY
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies